Eton Pharmaceuticals, Inc. · NASDAQ:ETON
Brynjelsen Sean sold 120,000 Eton Pharmaceuticals, Inc. shares (Form 4)
Traded May 28, 2026 · Filed May 29, 2026
On May 28, 2026, Brynjelsen Sean (Director, President & CEO) sold 120,000 Eton Pharmaceuticals, Inc. shares at an average US$31.88 for US$3.83M, leaving 833,694 shares. Filed May 29, 2026 (Form 4).
- Sold
- 120,000 shares
- Price
- US$31.88 average (US$31.88 to US$32.67)
- Value
- US$3.83M
- Holding after
- 833,694 shares
- Trading plan
- No
- Role
- Director, President & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 28, 2026 | Common Stock | Sale | 119,852 | US$31.88 | 833,842 | Direct |
| May 28, 2026 | Common Stock | Sale | 148 | US$32.67 | 833,694 | Direct |
Source
Related
- Eton Pharmaceuticals, Inc.
- Brynjelsen Sean
- Eton Pharmaceuticals, Inc. shareholders
- Form 4 · Brynjelsen Sean · Aug 20, 2026
- Form 4 · Brynjelsen Sean · Jul 14, 2026
- Form 4 · Krempa David · Oct 6, 2026
- Form 4/A · Maier Paul V · Aug 31, 2026
- Form 4 · Krempa David · Aug 24, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4/A · Opaleye Management Inc. · Jul 17, 2026